Doctors have successfully treated an infant with a rare childhood leukemia using a targeted therapy approved for adults with inoperable liver cancer and advanced kidney cancer. The decision to use the drug, sorafenib, was made after pathologists identified a unique mutation of two genes being fused together instead of on separate chromosomes.
From https://jamesjohnson10.blogspot.com/2019/09/infant-with-deadly-leukemia-saved-by.html
from
https://jamesjohnson10.wordpress.com/2019/09/12/infant-with-deadly-leukemia-saved-by-drug-for-adult-liver-cancer/
No comments:
Post a Comment